2019 論文・総説(国際)~Publications(International)~

1 Nrf2-related gene expression is impaired during a glucose challenge in type II diabetic rat hearts.
Thorwald MA, Godoy-Lugo JA, Rodriguez GJ, Rodriguez MA, Jamal M, Kinoshita H, Nakano D, Nishiyama A, Forman HJ, Ortiz RM.
Free Radic Biol Med. Volume130, 2019 Jan: 306-317.
2 (Pro)renin receptor promotes colorectal cancer through the Wnt/beta-catenin signalling pathway despite constitutive pathway component mutations.
Wang J. Shibayama Y, Zhang A, Ohsaki H, Asano E, Suzuki Y, Kushida Y, Kobara H, Masaki T, Wang Z, Nishiyama A.
Br J Cancer. 2019 Jan;120(2):229-237.
3 Effects of the novel nonsteroidal mineralocorticoid receptor blocker, esaxerenone (CS-3150), on blood pressure and urinary angiotensinogen in low-renin Dahl salt-sensitive hypertensive rats.
Li L, Guan Y, Kobori H, Morishita A, Koboara H, Masaki T, Nakano D, Nishiyama A.
Hypertens Res. 2019 Jun;42(6)769-778.
4 Effect of a novel nonsteroidal selective mineralocorticoid receptor antagonist, esaxerenone (CS-3150), on blood pressure and renal injury in high salt-treated type 2 diabetic mice.
Bhuiyan AS, Rafiq K, Kobara H, Masaki T, Nakano D, Nishiyama A.
Hypertens Res. 2019 Jun;42(6):892-902, .
5 Diuretic effects of sodium glucose cotransporter 2 inhibitors and their influence on the renin-angiotensin system.
Ansary TM, Nakano D, Nishiyama A.
Int J Mol Sci. 2019 Feb 1;20(3)
6 Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease.
Nishiyama A.
Hypertens Res. 2019 Mar;42(3):293-300.
7 The effects of a participatory structured group educational program on the development of CKD: a population-based study.
Sofue T, Okano Y, Matsushita N, Moritoki M, Nishijima Y, Fujioka H, Yamasaki Y, Yamanaka M, Nishiyama A, Minamino T
Clin Exp Nephrol. 2019 Apr;23(8):1031-1038.
8 JSH Statement: Asahikawa declaration in promotion of diversity by the Japanese society of hypertension-the JSH Asahikawa declaration.
Nakamura S, Hasebe N, Yatabe M, Kishi T, Ishida M, Ichihara A, Node K, Ishimitsu T, Itoh H, Ito M, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nishiyama A, Higaki J, Miura K, Rakugi H, Kawano Y, Tamura K, Yatabe T, Ohya Y, Ito S.
Hypertens Res. 2019 Apr;42:1483-1484.
9 Parametric standing wave generation of a shallow reflection plane in a nonrigid sample for use in a noninvasive blood glucose monitor.
Kitazaki T, Kawashima N, Yamamoto N, Nomura H, Kang H, Nishiyama A, Wada K, Ishimaru I.
J Biomed Opt. 2019 Mar;24(3):1-7.
10 JSH Statement: Kyoto declaration on hypertension research in Asia.
Ito M, Ishimitsu T, Ichihara A, Itoh H, Ohishi M, Ohkubo T, Kai H, Kashihara N, Kario K, Saitoh S, Tsuchihashi T, Nakamura S, Nishiyama A, Node K, Hasebe N, Higaki J, Miura K, Rakugi H, Tamura K, Kawano Y, Yatabe T, Ohya Y, Ito S.
Hypertens Res. 2019 Jan;42(6):759-760.
11 Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type2 diabetes.
Takenaka T, Kobori H, Miyazaki T, Suzuki H, Nishiyama A, Ishii N, Yamashita M, Hayashi M.
Acta Physiologica (Oxf). Feb; 225(2): e13190, 2019
12 Podocyte injury augments intrarenal angiotensin II generation and sodium retention in a megalin-dependent manner.
Koizumi M, Ueda K, Niikura F, Nishiyama A, Yanagita M, Saito A, Pastan I, Fujita T, Fukagawa M, Matsusaka T.
Hypertension. 2019 Jul;74(3):509-517.
13 A mouse model of renal fibrosis to overcome the technical variability in ischaemia/reperfusion injury among operators.
Guan Y, Nakano D, Zhang Y, Li L, Tian Y, Nishiyama A.
Scientific Reports 2019 Jul, 18;9(1):10435.
14 The p21 Dependent G2 Arrest of the Cell Cycle in Epithelial Tubular Cells Links to the Early Stage of Renal Fibrosis
Koyano T, Namba M, Kobayashi T, Nakakuni K, Nakano D, Fukushima M, Nishiyama A, Matsuyama M
Sci Rep, 2019: 9(1),12059.
15 (Pro)renin Receptor Accelerates Development of Sarcopenia via Activation of Wnt/YAP Signaling Axis
Yoshida A, Endo J, Kinouchi K, Kitakata H, Moriyama H, Kataoka M, Yamamoto T, Shirakawa K, Morimoto S, Nishiyama A, Hashiguchi A, Higuchi I, Fukuda K, Ichihara A, Sano M
Aging Cell, 2019; 18(5),e12991.
16 Ultra-miniature (diameter: 6 mm, thickness: 5 mm) low-cost (price: 1,000 EUR) point-one-shot mid-infrared Fourier spectroscopic imager for ear clip type non-invasive blood glucose sensors.
Natsumi Kawashima, Satoru Adachi, Tomoya Kitazaki, Hanyue Kang, Akira Nishiyama, Kenji Wada, Ichiro Ishimaru.
Proc. SPIE 11073, Clinical and Preclinical Optical DiagnosticsII (Vol. 110730, 110730H1~4) Jul. 2019